Press release
Antihypertensive Drugs Market Segments, Leading Player, Application and Forecast Analysis
Antihypertensive Drugs Market Outlook 2031• The global antihypertensive drugs market was valued at US$ 30.2 Bn in 2021
• The global market is projected to grow at a CAGR of 3.0% from 2022 to 2031
• The global antihypertensive drugs market is anticipated to reach more than US$ 40 Bn by the end of 2031
Analysts' Viewpoint on Antihypertensive Drugs Market Scenario
Increase in launch of new drugs and diagnostic agents; and key industry developments such as collaborations and establishment of new R&D centers are likely to propel the global antihypertensive drugs market. In 2017, Abbott Laboratories opened a new China R&D center to meet the evolving healthcare needs of local consumers in Shanghai. Daiichi Sankyo collaborated with the University of California San Francisco's Institute for Neurodegenerative Diseases for joint research and development of drugs and diagnostic agents for various neurodegenerative diseases. Rise in disposable income and launch of new disease-modifying therapies are projected to propel the global antihypertensive drugs market during the forecast period. Significant growth in telemedicine and e-Health apps is also likely to create long-term revenue opportunities for companies in the antihypertensive drugs market.
Read Report Overview- https://www.transparencymarketresearch.com/antihypertensive-drugs-market.html
Overview of Antihypertensive Drugs Market
Antihypertensive medications are used to treat high blood pressure. Different types of antihypertensive drugs are available in the market. These help lower blood pressure. Some remove excess fluid and salt from the body, while others help relax and widen blood vessels or slow the heart rate. A person could respond better and experience fewer side effects to one drug than to another. Some patients require more than one antihypertensive agent to lower blood pressure.
Hypertension is a preventable risk factor for atherosclerotic disease and ischemic heart disease. A number of patients maintain suboptimal blood pressure control despite the availability of modern and effective antihypertensive drugs. Most hypertensive patients require a combination of antihypertensive agents to achieve treatment goals. Under combination therapy, another class of blood pressure medication is added to the first drug to increase its effectiveness. The antihypertensive drugs market has reasonably high unmet demand, which indicates the lack of effective products. This presents significant opportunities for new entrants to capitalize on the unmet needs, largely due to poor patient compliance with products currently available in the market.
Request a Sample of Antihypertensive Drugs Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7718
Trends in antihypertensive medication in stroke survivors could provide important insights into gaps in secondary prevention that can guide improved interventions in the future. Healthcare companies are increasing R&D in the field of genomics and resistant hypertension treatment to gain a competitive edge over other market players.
Enquiry before Buying Antihypertensive Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=7718
Launch of New Disease-modifying Therapies to Drive Global Antihypertensive Drugs Market
Innovative antihypertensive drugs and drug therapies are expected to offer favorable outcomes, as these effectively target disease progression. The current scenario in the global antihypertensive drugs market is expected to change due to the launch of new therapies for diseases such as angiotensin II receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, and calcium channel blockers (CCB) during the forecast period.
Currently, physicians prescribe fewer diuretics and beta-blockers, common first-line agents for hypertension, and more ACE and CHF inhibitors. ACE inhibitors reduce mortality and morbidity in cardiovascular patients; however, this is not true for CCBs. If control is not available on beta-blockers, diuretics, or ACE inhibitors, short-acting CHFs should be avoided and alternatives should be considered. Unlike ACE inhibitors, ARBs do not cause cough. Therefore, launch of innovative drug/therapeutic molecules with disease-modifying properties and improved efficacy and safety is expected to drive the global antihypertensive drugs market in the next few years.
More Trending Reports by Transparency Market Research:
Alpha 1 Antitrypsin Deficiency Treatment Market- https://www.transparencymarketresearch.com/alpha-1-antitrypsin-deficiency-treatment-market.html
Sterilization Equipment and Disinfectant Market- https://www.transparencymarketresearch.com/sterilization-equipment-market.html
Wound Debridement Market- https://www.transparencymarketresearch.com/wound-debridement-market.html
Ophthalmic Drugs Market- https://www.transparencymarketresearch.com/ophthalmic-drugs-market.html
Topical Pain Management Therapeutics in Sports Medicine Market- https://www.transparencymarketresearch.com/topical-pain-management-therapeutics-sports-medicine-market.html
Respiratory Disorders Treatment Market- https://www.transparencymarketresearch.com/respiratory-disorders-treatment-market.html
Cryptococcosis Market- https://www.transparencymarketresearch.com/cryptococcosis-market.html
Non-alcoholic Steatohepatitis (NASH) Biomarkers Market- https://www.transparencymarketresearch.com/non-alcoholic-steatohepatitis-biomarkers-market.html
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antihypertensive Drugs Market Segments, Leading Player, Application and Forecast Analysis here
News-ID: 2692629 • Views: …
More Releases from Transparency Market Research
Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 …
The global silicon carbide (SiC) ceramics market continues to demonstrate strong growth potential, underpinned by accelerating demand from advanced industrial and electronic applications. Valued at US$ 1.8 Billion in 2024, the market is projected to reach US$ 3.1 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2035. This steady expansion reflects the increasing importance of SiC ceramics as…
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising D …
The global Furfuryl Alcohol Market was valued at US$ 624.3 million in 2024 and is projected to reach US$ 1,341.2 million by 2035, expanding at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2035.
This growth is primarily driven by the rising demand for bio-based and sustainable chemicals, along with the steady expansion of the foundry and metal casting industry, particularly across emerging economies in Asia Pacific.
Gain a…
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by …
The global Air-Entraining Agents (AEAs) Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 2.48 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2035. This steady growth trajectory reflects the essential role AEAs play in modern concrete formulations, particularly in infrastructure projects that demand long-term durability, freeze-thaw resistance, and improved workability.
Despite being a mature segment within…
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn …
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintain…
More Releases for Antihypertensive
Antihypertensive Drugs Market Future Prediction Report By 2033
The global Antihypertensive Drugs Market was valued at approximately USD 30.5 billion in 2024 and is projected to reach around USD 38.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2025 to 2033 .
Antihypertensive Drugs Market Overview
The global Antihypertensive Drugs Marke is driven by the rising global burden of hypertension, especially among the elderly and individuals with lifestyle-related risk factors such as obesity, poor…
Antihypertensive Drugs Market Segmentation, and Future Growth Prospects
In recent years, the global Antihypertensive Drugs Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Antihypertensive Drugs Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Antihypertensive Drugs Market Size to Reach USD 10 Billion 2030
Exclusive Report by Ameco Research: Antihypertensive Drugs Market Size Projected to Reach USD 52 Billion by 2030, Growing at 4.70% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Antihypertensive Drugs Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Antihypertensive Drugs Market to Develop Rapidly by 2031, TMR Study
The global Antihypertensive Drugs Market market is estimated to attain a valuation of US$ 40 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3% during the forecast period, 2022 to 2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major…
Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ev …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 4.87% during the forecast period. Hypertension is a medical condition that results in a rise in blood pressure in the arteries. Hypertension may lead to numerous serious complications including heart failure, aneurysm, heart attacks, and dementia. To prevent the serious effects of hypertension early diagnosis…
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best…
